ARCHIVES

Low Prevalence Of Tamoxifen Use For Cancer Prevention

This article is from The Cancer Letter archive.

Vol. 33 No. 2 | February 26, 2010

Download PDF Visit The Full Archive

Related Articles

Phase III Regorafenib Trial Meets Endpoint Improving Progression-Free Survival

April 27, 2012

Controlling Diabetes May Cut Liver Cancer Risk, Study Finds

April 30, 2010

Wyngaarden Recommendation On New Director Due Nov. 1o; Five Staff Members Nominated

November 4, 1988

Totality Of Evidence Causes Concern About New Findings.

December 7, 2007

In congress: Sen. Harkin: “What Causes Cancer” If We Don’t Know The Cause, How Can We Get Into Prevention?

June 27, 1997

New Grants Awarded In Tobacco Research

February 17, 1978